These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26491664)

  • 61. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acetaminophen-induced liver injury in obesity and nonalcoholic fatty liver disease.
    Michaut A; Moreau C; Robin MA; Fromenty B
    Liver Int; 2014 Aug; 34(7):e171-9. PubMed ID: 24575957
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype.
    Cuff AO; Sillito F; Dertschnig S; Hall A; Luong TV; Chakraverty R; Male V
    Front Immunol; 2019; 10():2180. PubMed ID: 31572388
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The organ specificity in pathological damage of chronic intermittent hypoxia: an experimental study on rat with high-fat diet.
    Wang H; Tian JL; Feng SZ; Sun N; Chen BY; Zhang Y
    Sleep Breath; 2013 Sep; 17(3):957-65. PubMed ID: 23114729
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.
    Anavi S; Madar Z; Tirosh O
    Redox Biol; 2017 Oct; 13():386-392. PubMed ID: 28667907
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease.
    Byun JS; Yi HS
    Biomed Res Int; 2017; 2017():6862439. PubMed ID: 28852648
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of HIF in immunity and inflammation.
    Cummins EP; Keogh CE; Crean D; Taylor CT
    Mol Aspects Med; 2016; 47-48():24-34. PubMed ID: 26768963
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Liver-spleen axis in nonalcoholic fatty liver disease.
    Tarantino G; Citro V; Balsano C
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):759-769. PubMed ID: 33878988
    [No Abstract]   [Full Text] [Related]  

  • 71. Hypoxia and Non-alcoholic Fatty Liver Disease.
    Isaza SC; Del Pozo-Maroto E; Domínguez-Alcón L; Elbouayadi L; González-Rodríguez Á; García-Monzón C
    Front Med (Lausanne); 2020; 7():578001. PubMed ID: 33195326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of lipids in the metabolism and activation of immune cells.
    Hubler MJ; Kennedy AJ
    J Nutr Biochem; 2016 Aug; 34():1-7. PubMed ID: 27424223
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical advances in pediatric nonalcoholic fatty liver disease.
    Schwimmer JB
    Hepatology; 2016 May; 63(5):1718-25. PubMed ID: 27100147
    [No Abstract]   [Full Text] [Related]  

  • 74. [Obstructive sleep apnea hypopnea syndrome and nonalcoholic fatty liver disease].
    Chen L; Lin Q
    Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):393-6. PubMed ID: 26427074
    [No Abstract]   [Full Text] [Related]  

  • 75. Hypoxia and hypoxia inducible factors: diverse roles in liver diseases.
    Nath B; Szabo G
    Hepatology; 2012 Feb; 55(2):622-33. PubMed ID: 22120903
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Progress in research on obstructive sleep apnea hypopnea syndrome and nonalcoholic fatty liver disease].
    Zhang HJ; Liu HG
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jul; 43(7):588-591. PubMed ID: 32629560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progress in the study on innate immunity and non-alcohol fatty liver disease.
    Lou J; Yan G; Huang Z; Yuan H; Lu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1464-1468. PubMed ID: 33473004
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Innate immune activation in obesity.
    Lumeng CN
    Mol Aspects Med; 2013 Feb; 34(1):12-29. PubMed ID: 23068074
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease.
    Vos MB
    Hepatology; 2013 Jul; 58(1):4-5. PubMed ID: 23504746
    [No Abstract]   [Full Text] [Related]  

  • 80. Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea?
    Mirrakhimov AE; Mirrakhimov EM
    Can J Cardiol; 2013 Sep; 29(9):1139.e7. PubMed ID: 23265092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.